Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 4 / 70
236 personsTwo hundred thirty-six (48.7%) respondents had received HIV and sexual and reproductive health services through peer-led facilities.
Nigeriasexual and reproductive health · VIH/sidapublished 2019BMC health services researchPubMeddocument of 3 observations
96 %Retention rates at 6 months exceeded 96% for all differentiated service delivery models compared to 94% among those continuing standard care.
NigeriaVIH/sidapublished 2021Journal of the International AIDS SocietyPubMeddocument of 6 observations
Joint and muscle pain were the most commonly reported symptoms among HIV-positive participants in the study.
Nigeriacytomegalovirus (CMV) · VIH/sidapublished 2025Journal of infection in developing countriesPubMeddocument of 2 observations
18.2 %Prevalence of HIV among liver diseases patients in Osun State was 18.2%.
NigeriaVIH/sidapublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 4 observations
Significant increases in the glucogenic, aromatic and branched-chain amino acid concentrations were observed in the HIV/HBV co-infected subjects.
Nigeriahépatite B · VIH/sidapublished 2022African health sciencesPubMeddocument of 3 observations
1 %The prevalence of uveitis among persons living with HIV/AIDS in Osun State, Nigeria was 1%.
Nigeriauveitis · VIH/sidapublished 2026BMC ophthalmologyPubMeddocument of 9 observations
20.5 %Surveillance drug resistance mutations (SDRMs) were observed in 8 of 39 incident HIV cases (20.5%) from March 2013 to June 2017 in Lagos and Abuja, Nigeria.
NigeriaVIH/sidaobserved March 2013 to June 2017published 2019Antiviral therapyPubMeddocument of 6 observations
0 %Using malaria microscopy, the prevalence of malaria parasitaemia was 0% in first-line cART-experienced HIV-infected persons.
Nigeriapaludisme · VIH/sidaobserved 2018–2019published 2024BMC infectious diseasesPubMeddocument of 15 observations
11,294 servicesThe average annual number of HIV education (HIVE) services provided per community-based organization (CBO) in Nigeria was 11,294.
NigeriaVIH/sidaobserved 2016published 2023PloS onePubMeddocument of 10 observations
2.04 t_statisticThere was a statistically significant reduction in self-reported depressive symptoms among youth living with HIV at 48 weeks compared to baseline (mean 2.89 vs 2.08; t36=2.04, 95% CI 0.006–1.615).
NigeriaVIH/sidapublished 2025JMIR formative researchPubMeddocument of 7 observations
4.4 aORFemale sex workers residing in the North West geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 4.40).
NigeriaVIH/sidapublished 2024International journal of STD & AIDSPubMeddocument of 12 observations
24,700,000 inhabitantsSub-Saharan Africa houses over two-thirds of the 37 million people living with HIV globally.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations
35.5 %35.5% of anaemia cases were due to infections only, predominantly HIV and malaria.
Nigeriaanémie · paludisme · VIH/sidapublished 2020African health sciencesPubMeddocument of 5 observations
23 %Thirteen (23%) patients were resistant to at least one antiretroviral drug.
NigeriaVIH/sidapublished 2020BMC microbiologyPubMeddocument of 7 observations
0.7 yearsThe mean age of 57 HIV-infected, HIV-exposed infants in Plateau State, Nigeria at antiretroviral therapy initiation was 0.7 years (8.9 months) ± 0.7 years.
NigeriaVIH/sidaobserved 2018–2022published 2026PloS onePubMeddocument of 13 observations
21.9 %LGA-level antiretroviral therapy (ART) coverage among adults living with HIV in Nigeria ranged from 21.9% to 81.9% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.
NigeriaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 5 observations
81.5 %81.5% of young adolescents in Akwa Ibom State, Nigeria reported stigmatizing tendencies towards people living with HIV.
NigeriaVIH/sidaobserved 2017published 2020BMC public healthPubMeddocument of 5 observations
82.4 %14 (82.4%) of the laboratories had 'low capacity' to detect CD4 count and HIV antibodies in blood serum.
NigeriaVIH/sidapublished 2022Microbiology spectrumPubMeddocument of 6 observations
There was no statistically significant change in the CD4 counts (456 cells/mm3 vs 481 cells/mm3, P=0.489) after one year of devolvement into the community.
NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 10 observations
8 %Among 224 HIV-1 infected samples from 6 Nigerian cities, 8% were nontypeable strains.
NigeriaVIH/sidapublished 2016MedicinePubMeddocument of 7 observations
27.1 %The prevalence of intestinal helminthiasis among HIV-infected children attending the University of Nigeria Teaching Hospital was 27.1%.
Nigeriaintestinal helminthiasis · VIH/sidapublished 2024Nigerian journal of clinical practicePubMeddocument of 4 observations
23.1 %The cure rate of TB patients coinfected with human immunodeficiency virus (HIV) was 23.1%.
Nigeriatuberculose · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
70,210 testsA total of 70,210 children were tested for HIV within the six-month period.
NigeriaVIH/sidapublished 2023BMC pediatricsPubMeddocument of 10 observations
19.7 %Among HIV-positive clients in Makurdi, Benue state, Nigeria, tobacco products were used by 19.7%.
NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 7 observations
44.6 %44.6% of entries were submitted via offline Dropbox.
NigeriaVIH/sidaobserved October 2018 to June 2019published 2020PloS onePubMeddocument of 10 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.